Cortexyme Inc

Company Profile

Cortexyme Inc had its IPO on 2019-05-09 under the ticker symbol QNCX.

The company operates in the Healthcare sector and Biotechnology industry. Cortexyme Inc has a staff strength of 21 employees.

Stock update

Shares of Cortexyme Inc opened at $1.24 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.23 - $1.28, and closed at $1.23.

This is a -3.15% slip from the previous day's closing price.

A total volume of 31,898 shares were traded at the close of the day’s session.

In the last one week, shares of Cortexyme Inc have slipped by -5.38%.

Cortexyme Inc's Key Ratios

Cortexyme Inc has a market cap of $47.30 million, indicating a price to book ratio of 0.234 and a price to sales ratio of 0.

In the last 12-months Cortexyme Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-25654000. The EBITDA ratio measures Cortexyme Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cortexyme Inc’s operating margin was 0% while its return on assets stood at -15.57% with a return of equity of -30.84%.

In Q2, Cortexyme Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cortexyme Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.81 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cortexyme Inc’s profitability.

Cortexyme Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.0189. Its price to sales ratio in the trailing 12-months stood at 0.

Cortexyme Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$88.84 million

Total Liabilities

$1.95 million

Operating Cash Flow

$-20323000.00

Capital Expenditure

$0

Dividend Payout Ratio

0%

Cortexyme Inc ended 2024 with $88.84 million in total assets and $0 in total liabilities. Its intangible assets were valued at $88.84 million while shareholder equity stood at $86.88 million.

Cortexyme Inc ended 2024 with $0 in deferred long-term liabilities, $1.95 million in other current liabilities, 36000.00 in common stock, $-305399000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $22.65 million and cash and short-term investments were $87.57 million. The company’s total short-term debt was $147,000 while long-term debt stood at $0.

Cortexyme Inc’s total current assets stands at $88.55 million while long-term investments were $78000.00 and short-term investments were $64.92 million. Its net receivables were $0 compared to accounts payable of $353000.00 and inventory worth $0.

In 2024, Cortexyme Inc's operating cash flow was $-20323000.00 while its capital expenditure stood at $0.

Comparatively, Cortexyme Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.23

52-Week High

$1.93

52-Week Low

$0.54

Analyst Target Price

$3

Cortexyme Inc stock is currently trading at $1.23 per share. It touched a 52-week high of $1.93 and a 52-week low of $1.93. Analysts tracking the stock have a 12-month average target price of $3.

Its 50-day moving average was $1.33 and 200-day moving average was $1.21 The short ratio stood at 4.25 indicating a short percent outstanding of 0%.

Around 2164.6% of the company’s stock are held by insiders while 2524.9% are held by institutions.